Foamix Enters Manufacturing Agreement with ASM Aerosol-Service for Topical Foam Treatment
Through the agreement, Foamix will have access to $20 million of financing to fund the commercial launches of the topical treatments.
Foamix Pharmaceuticals, a specialty pharmaceutical company based in Israel, announced a long term contract manufacturing and supply agreement with ASM Aerosol-Service, a liquid and semi-liquid product contract manufacturer in Switzerland, for ASM’s AMZEEQ (minocycline), a topical foam for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and pediatric patients, and FMX103 (minocycline), a topical foam for treatment of moderate to severe papulopustular rosacea in adults.
Through the agreement, Foamix will have access to $20 million of financing under its existing credit agreement with Perceptive and OrbiMed to fund the commercial launches of AMZEEQ and, pending FDA approval, FMX103, according to an Oct. 23, 2019 press release.
“This agreement represents another milestone in our overall strategy to bring AMZEEQ to market in January 2020 and to commercialize FMX103 when and if approved by [FDA],” said David Domzalski, CEO of Foamix, in the press release. “Entering into a manufacturing contract with ASM is a critical step in securing our supply chain, which we believe will ensure the availability of supply once we launch AMZEEQ and, if approved, FMX103.”
Source: Foamix
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
